Minimal Hepatic Encephalopathy (MHE) is characterized by an impairment of social interaction, emotional behavior, sleep disorders, physical and mental symptoms, and diminished Quality of Life (QoL). The aim of our study is evaluating the potential liver health promoting a perspective of Resveratrol (RV) activities and evaluate whether RV treatment may improve health related quality of life (HRQL) and reduce depression and anxiety in patients with MHE.
Resveratrol in Patients with Minimal Hepatic Encephalopathy
Malaguarnera, Giulia
;Pennisi, ManuelaMembro del Collaboration Group
;Bertino, GaetanoConceptualization
;Motta, MassimoMembro del Collaboration Group
;Borzì, Antonio MariaMembro del Collaboration Group
;Vicari, EnzoMembro del Collaboration Group
;Bella, RitaMembro del Collaboration Group
;Drago, FilippoMembro del Collaboration Group
;Malaguarnera, MicheleConceptualization
2018-01-01
Abstract
Minimal Hepatic Encephalopathy (MHE) is characterized by an impairment of social interaction, emotional behavior, sleep disorders, physical and mental symptoms, and diminished Quality of Life (QoL). The aim of our study is evaluating the potential liver health promoting a perspective of Resveratrol (RV) activities and evaluate whether RV treatment may improve health related quality of life (HRQL) and reduce depression and anxiety in patients with MHE.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Resveratrol in Patients with Minimal nutrients-10-00329.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Dimensione
669.93 kB
Formato
Adobe PDF
|
669.93 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
